IL98968A - תערובת רוקחות בעלי תולדות פנילפטאלןעבור טיפול בהפרעות ציריברוסקולריות - Google Patents

תערובת רוקחות בעלי תולדות פנילפטאלןעבור טיפול בהפרעות ציריברוסקולריות

Info

Publication number
IL98968A
IL98968A IL9896891A IL9896891A IL98968A IL 98968 A IL98968 A IL 98968A IL 9896891 A IL9896891 A IL 9896891A IL 9896891 A IL9896891 A IL 9896891A IL 98968 A IL98968 A IL 98968A
Authority
IL
Israel
Prior art keywords
treatment
citalopram
medicament
cerebral
dementia
Prior art date
Application number
IL9896891A
Other languages
English (en)
Other versions
IL98968A0 (en
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26066379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL98968(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL98968A0 publication Critical patent/IL98968A0/xx
Publication of IL98968A publication Critical patent/IL98968A/he

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL9896891A 1990-09-06 1991-07-25 תערובת רוקחות בעלי תולדות פנילפטאלןעבור טיפול בהפרעות ציריברוסקולריות IL98968A (he)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK213290A DK213290D0 (da) 1990-09-06 1990-09-06 Treatment of cerebrovascular disorders
SG165594A SG165594G (en) 1990-09-06 1994-11-16 1-[3-(dimethylamino)propyl]-1-phenylphthalenes for the treatment of cerebrovascular disorders

Publications (2)

Publication Number Publication Date
IL98968A0 IL98968A0 (en) 1992-07-15
IL98968A true IL98968A (he) 1996-06-18

Family

ID=26066379

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9896891A IL98968A (he) 1990-09-06 1991-07-25 תערובת רוקחות בעלי תולדות פנילפטאלןעבור טיפול בהפרעות ציריברוסקולריות

Country Status (14)

Country Link
EP (1) EP0474580B1 (he)
JP (1) JPH085787B2 (he)
KR (1) KR970002246B1 (he)
AT (1) ATE112166T1 (he)
AU (1) AU644204B2 (he)
CA (1) CA2049368C (he)
DE (1) DE69104314T2 (he)
DK (2) DK213290D0 (he)
HK (1) HK21595A (he)
IE (1) IE72160B1 (he)
IL (1) IL98968A (he)
NZ (1) NZ239437A (he)
SG (1) SG165594G (he)
ZA (1) ZA916187B (he)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69801764T2 (de) * 1997-07-08 2002-07-04 Lundbeck & Co As H Verfahren zur herstellung von citalopram
JP4674339B2 (ja) * 1998-08-07 2011-04-20 三菱化学株式会社 脳損傷の予防・治療剤
US6365747B1 (en) * 1998-10-20 2002-04-02 H. Lundbeck A/S Method for the preparation of citalopram
EP1140886B1 (en) 1998-12-23 2003-04-02 H. Lundbeck A/S Method for the preparation of 5-cyanophthalide
CA2291129C (en) 1999-04-14 2002-10-22 H. Lundbeck A/S Method for the preparation of citalopram
ITMI991581A1 (it) * 1999-06-25 2001-01-15 Lundbeck & Co As H Metodo per la preparazione di citalopram
AR021155A1 (es) 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
GB2357762B (en) 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
BG64901B1 (bg) * 2000-05-29 2006-08-31 H. Lundbeck A/S Метод за получаване на циталопрам
CA2354877C (en) 2000-08-18 2006-05-02 H. Lundbeck A/S Method for the preparation of citalopram
CA2360303C (en) * 2000-12-22 2003-08-12 Marco Villa Process for the preparation of pure citalopram
BG65515B1 (bg) * 2002-07-26 2008-10-31 H. Lundbeck A/S Метод за получаване на 5-цианофталид
ES2515092T3 (es) 2003-12-11 2014-10-29 Sunovion Pharmaceuticals Inc. Combinación de un sedante y un modulador neurotransmisor y métodos de mejorar la calidad del sueño y de tratar la depresión
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
EP2008653A1 (de) * 2007-06-28 2008-12-31 Charité-Universitätsmedizin Berlin Serotonerge Verbindungen zur Behandlung neuronaler Krankheiten
DE102007051090A1 (de) 2007-06-28 2009-01-08 Charité - Universitätsmedizin Berlin SSRI zur Behandlung neuronaler Krankheiten
CN104005415B (zh) * 2014-02-18 2015-12-02 中铁十六局集团北京轨道交通工程建设有限公司 微风化花岗岩中地下连续墙的高效成槽施工方法
CN106871753B (zh) * 2017-01-04 2018-10-16 中铁隧道集团有限公司 一种用于提高水平岩层隧道成型的装药方法

Also Published As

Publication number Publication date
JPH085787B2 (ja) 1996-01-24
SG165594G (en) 1995-05-12
ZA916187B (en) 1992-04-29
DE69104314D1 (de) 1994-11-03
IL98968A0 (en) 1992-07-15
AU644204B2 (en) 1993-12-02
NZ239437A (en) 1997-02-24
EP0474580A2 (en) 1992-03-11
AU8259491A (en) 1992-03-12
KR970002246B1 (ko) 1997-02-26
DK0474580T3 (da) 1995-04-03
IE72160B1 (en) 1997-03-26
EP0474580B1 (en) 1994-09-28
JPH04244024A (ja) 1992-09-01
CA2049368A1 (en) 1992-03-07
KR920005983A (ko) 1992-04-27
DE69104314T2 (de) 1995-02-16
EP0474580A3 (en) 1992-06-03
IE912682A1 (en) 1992-03-11
HK21595A (en) 1995-02-24
CA2049368C (en) 2001-10-23
DK213290D0 (da) 1990-09-06
ATE112166T1 (de) 1994-10-15

Similar Documents

Publication Publication Date Title
US5296507A (en) Treatment of cerbrovascular disorders
CA2049368C (en) Treatment of cerebro-vascular disorders
JP3984787B2 (ja) 機能性及び／又は器質性痛み症候群の治療のための製薬組成物の調製のためのアセチルコリンエステラーゼ阻害剤の使用
US5962535A (en) Composition for alzheimer's disease
EP0306060B1 (en) Pharmaceutical products providing enhanced analgesia
KR100342762B1 (ko) 활성성분으로서치환된펜에틸아민을포함하는약제학적조성물
US4916125A (en) Method of treating migraine
GB2259013A (en) Neuroprotective use of CCK antagonists
KR20010032009A (ko) 수면성 무호흡의 치료에 미타자핀을 사용하는 방법
US7297691B2 (en) Treatment of sleep disorders with cholinesterase inhibitors
JP2021167361A (ja) 神経変性障害を処置するための方法
WO2002043726A1 (en) Method for inducing cognition enhancement by use of trimethyl-bicyclo[2.2.1]heptane derivatives
AU639722B2 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
CA2369638A1 (en) Use of osanetant in the production of medicaments used to treat mood disorders
KR0177894B1 (ko) 항우울제
Shimizu-Sasamata et al. Cerebral activating properties of indeloxazine HCl and its optical isomers
EP0334674B1 (en) Use of isoxazolinones as cerebro-active drugs
Gaillard et al. Paradoxical sleep rebound without previous debt: the effect of minute doses of clonidine in man
US5182276A (en) Nootropic agent
US4609656A (en) Medical agent for improving and treating mental symptoms induced by cerebral disturbances
WO1998031356A1 (en) Idebenone containing combination agent for treating alzheimer's disease
US5010096A (en) Method of protecting mammals against neuronal damage resulting from cerebral ischemia
US6680331B2 (en) Lactam and thiolactam derivatives as anesthetic and conscious sedation agents
WO2005072728A1 (en) Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
HU190714B (en) Process for the preparation of pharmaceutical compositions containing dibenzocycloheptadiene antidepressant and ergot alkaloid

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired